Why would we care noise when we have fast track/priority review covid drug Aviptadil. No pharma had fast track designation so far except RLFTF. Let FDA and Data Monitoring Committee speak out about our covid drug.
dude..so the million dollar question is how can mgmt push the float down without resorting to a reverse split? Buying back and retiring shares is highly unlikely at this juncture.